GILD


Insider Selling News: Gilead Sciences, Inc. (GILD), Skyworks Solutions Inc (SWKS), Facebook Inc (FB), Micron Technology, Inc. (MU)

Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Skyworks Solutions Inc (NASDAQ:SWKS), Facebook Inc (NASDAQ:FB), and Micron Technology, Inc.

Stock Update (NASDAQ:GILD): EMA Validates Gilead Sciences, Inc.’s Application for Fixed-Dose Combo of Emtricitabine and Tenofovir Alafenamide for HIV Treatment

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the company’s Marketing Authorization Application (MAA) for two doses of an investigational fixed-dose combination of emtricitabine and …

Gilead Sciences, Inc. (GILD) Stock Declines On HCV Sales Issues; What’s Next?

Gilead Sciences, Inc. (NASDAQ:GILD) has made a major name for itself in the healthcare market; taking the hepatitis C virus and HIV treatment …

Has Gilead Sciences, Inc. (GILD) Found A Way To Cure HIV?

­ Gilead Sciences, Inc. (NASDAQ:GILD) I recently wrote an article about a new experimental drug Gilead was working on that could end up …

Insider Selling News: Gilead Sciences, Inc. (GILD), Walt Disney Co (DIS), Facebook Inc (FB), Twitter Inc (TWTR)

Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Walt Disney Co (NYSE:DIS), Facebook Inc (NASDAQ:FB), and Twitter …

Why Gilead Sciences, Inc. (GILD) Should Buy Out Achillion Pharmaceuticals, Inc. (ACHN)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Gilead Sciences, Inc.

Gilead Sciences, Inc. (GILD) May Have Found A Cure For HIV

Gilead Sciences, Inc. (NASDAQ:GILD) When you think of Gilead Sciences, what’s the first thing that comes to mind.

Gilead Sciences, Inc. (GILD): No Need to Gild the Lily

Executive Summary Massive Q1 growth at Gilead Sciences, Inc. (NASDAQ:GILD) – 52% revenue growth, 85% net income growth Market fears that Gilead is …

Top-Ranked Analysts Are Bullish on Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) has been a favorite among biotech investors due to its successful hepatitis C therapies; Harvoni and Sovaldi.

Will Gilead Sciences, Inc (GILD) Acquire Vertex Pharmaceuticals Incorporated (VRTX) Despite its Short-Term Dominance In Cystic Fibrosis?

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) weekly options are pricing in a move of +/- $10 with Implied VOL currently in the 28th percentile over the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts